OBJECTIVES: We investigated the frequency of chemotherapy use and its associated factors in patients in all age groups in the last year of life. METHODS: We identified cancer patients who died in 2004 in any of 17 hospitals. We used demographic and treatment characteristics by computerized hospital information systems and by linking the identification numbers to the 2004 death registry. RESULTS: 48.7% of patients in the last 6 months of life, 43.9% in the last 3 months, and 30.9% in the last month of life received chemotherapy. The frequency of chemotherapy use was lower for older patients. In those > or =65 years old, there was no difference between women and men in the proportion that received chemotherapy. For patients <65 years of age, ...
Simple Summary</p>In the last decades, new treatment options for advanced (breast) cancer have...
[[abstract]]Background: The availability of new chemotherapeutic agents has lengthened the treatment...
[[abstract]]Background: The availability of new chemotherapeutic agents has lengthened the treatment...
Background: Although many observers believe that cancer che-motherapy is overused at the end of life...
BACKGROUND: Although many observers believe that cancer chemotherapy is overused at the end of life,...
The quality of medical care delivered to patients with cancer near the end of life is a significant ...
The quality of medical care delivered to patients with cancer near the end of life is a significant ...
Background: Information on medication use in the last months of life is limited. Aim: To describe w...
Background: It is important to know and decide when to end regimen for the quality of life of the pa...
Purpose: Despite advances in cancer treatment, patients still die with unnecessary suffering. Theref...
Purpose: Chemotherapy near the end of life is frequently considered as an indicator of inappropriate...
Purpose: Chemotherapy near the end of life is frequently considered as an indicator of inappropriate...
Objective: ensure a good quality of life in the last phase of onco- hematological patients should be...
Simple Summary</p>In the last decades, new treatment options for advanced (breast) cancer have...
Simple Summary</p>In the last decades, new treatment options for advanced (breast) cancer have...
Simple Summary</p>In the last decades, new treatment options for advanced (breast) cancer have...
[[abstract]]Background: The availability of new chemotherapeutic agents has lengthened the treatment...
[[abstract]]Background: The availability of new chemotherapeutic agents has lengthened the treatment...
Background: Although many observers believe that cancer che-motherapy is overused at the end of life...
BACKGROUND: Although many observers believe that cancer chemotherapy is overused at the end of life,...
The quality of medical care delivered to patients with cancer near the end of life is a significant ...
The quality of medical care delivered to patients with cancer near the end of life is a significant ...
Background: Information on medication use in the last months of life is limited. Aim: To describe w...
Background: It is important to know and decide when to end regimen for the quality of life of the pa...
Purpose: Despite advances in cancer treatment, patients still die with unnecessary suffering. Theref...
Purpose: Chemotherapy near the end of life is frequently considered as an indicator of inappropriate...
Purpose: Chemotherapy near the end of life is frequently considered as an indicator of inappropriate...
Objective: ensure a good quality of life in the last phase of onco- hematological patients should be...
Simple Summary</p>In the last decades, new treatment options for advanced (breast) cancer have...
Simple Summary</p>In the last decades, new treatment options for advanced (breast) cancer have...
Simple Summary</p>In the last decades, new treatment options for advanced (breast) cancer have...
[[abstract]]Background: The availability of new chemotherapeutic agents has lengthened the treatment...
[[abstract]]Background: The availability of new chemotherapeutic agents has lengthened the treatment...